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Abstract
Background: Imbalances in the functional binding of fibroblast growth factors (FGFs) to their receptors
(FGFRs) have consequences for cell proliferation and differentiation that in chondrocytes may lead to degraded
cartilage. The toxic, proinflammatory, and oxidative response of cytokines and FGFs can be mitigated by
dietary polyphenols.
Objective: We explored the possible effects of polyphenols in the management of osteoarticular diseases using
a model based on the transduction of a mutated human FGFR3 (G380R) in murine chondrocytes. This
mutation is present in most cases of skeletal dysplasia and is responsible for the overexpression of FGFR3
that, in the presence of its ligand, FGF9, results in toxic effects leading to altered cellular growth.
Design: Different combinations of dietary polyphenols derived from plant extracts were assayed in FGFR3
(G380R) mutated murine chondrocytes, exploring cell survival, chloride efflux, extracellular matrix (ECM)
generation, and grade of activation of mitogen-activated protein kinases.
Results: Bioactive compounds from Hibiscus sabdariffa reversed the toxic effects of FGF9 and restored normal
growth, suggesting a probable translation to clinical requests in humans. Indeed, these compounds activated
the intracellular chloride efflux, increased ECM generation, and stimulated cell proliferation. The inhibition
of mitogen-activated protein kinase phosphorylation was interpreted as the main mechanism governing these
beneficial effects.
Conclusions: These findings support the rationale behind the encouragement of the development of drugs that
repress the overexpression of FGFRs and suggest the dietary incorporation of supplementary nutrients in the
management of degraded cartilage.
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T
he available evidence no longer sustains the
concept that the biological activity of therapeutic
compounds is limited to unique and well-defined
mechanisms. Contrarily, the simultaneous and combined
use of active constituents, which is in line with the notion
that nutrients are associated with the preservation of
health status, supports the challenging search for novel
therapeutic targets among bioactive food components (1).
In this setting, polyphenols associate their intrinsic anti-
oxidant and anti-inflammatory properties with a syner-
gistic impact in metabolic functions and maintenance
of cellular homeostasis (2). The intimate mechanism(s) is
not completely understood but is probably associated
with gene expression pathways that coordinate important
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intracellular signaling pathways (3, 4). One of the most
important ways to maintain correct cell growth and dif-
ferentiation is via the signal transduction cascade, acti-
vated by the binding of growth factors to their receptors.
In particular, fibroblast growth factors (FGFs) are crucial
in the regulation of tissue formation (5), and the potential
effects of altered interactions between FGFs and their
receptors (FGFRs) are attractive targets to be explored in
the relationship between food intake and disease (6).
In humans, the binding of growth factors to specific
receptors results in a pleiotropic response derived from the
distinct tissue distribution and the complexity of these
families of proteins. However, their immediate action comes
from the activation and/or dysfunction of phosphoryla-
tion events in important signaling pathways. Dietary poly-
phenols are probable candidates to modulate and regulate
disturbances in these pathways through relevant key mole-
cules, including phospholipase C gamma (PLCg) (7), the
signal transducer and activator of transcription (STAT)
protein (8), phosphoinositol-3 kinase/protein kinase B
(PI-3K/AKT) (9), and rat sarcoma protein/mitogen acti-
vated protein kinase (RAS/MAPK [ERK-1/-2]) (10). It
is therefore expected that human nutrition and growth
factors are associated with inflammatory and metabolic
disturbances (1114). Moreover, point mutations in FGFRs
affecting the function of FGFs-activated receptors have
been shown to be consistently involved in cancer (1517),
atherosclerosis (18), and dysfunctions in growth and
development (19, 20).
For the purpose of this study, we highlight the fact
that unambiguous functional mutations in FGFR3 are
involved in several diseases (21, 22), including skeletal
dysplasia and osteoarthritis (23, 24). Because dietary poly-
phenols block the actions of some cytokines and FGFs
that lead to cartilage degradation (25), we have tested the
hypothesis that dietary polyphenols might have an im-
portant regulatory effect on the functional binding of
FGFs to their receptors. We used murine chondrocytes
to transduce a human mutated FGFR3 by substituting
glycine with arginine at position 380 (G380R), which
causes achondroplasia. When the receptor is activated by
its specific ligand (FGF9), this mutation produces severe
changes in cellular growth. We have previously shown
(2628) that this model is sensitive for gaining insight into
the management of diseases associated with dysfunctions
in cartilage. To reduce the complexities found in the com-
position of plant foods, but preserving the multiple and
synergistic effects provided by the combination of multiple
compounds, we have employed several fully characterized,
polyphenol-rich plant extracts. The hypothesis is relevant
because repression of mutated FGFR3 might illustrate
the potential reversibility of a genetic condition and the
feasibility of alternative therapeutic strategies (29, 30).
Our findings support the view that the dietary incorpora-
tion of supplementary nutrients may be safely utilized to
regulate intracellular signaling networks in the manage-
ment of degraded cartilage phenotypes.
Material and methods
Chemical and reagents
Tetracycline, minimum essential medium alpha (a-MEM),
heat-inactivated fetal bovine serum, and antibiotics
(penicillin, Geneticin, streptomycin, and hygromycin) were
obtained from Invitrogen (Carlsbad, CA, USA). Tris base,
NaCl, NP-40, sodium deoxycholate, SDS, TWEEN-20,
BSA, phenylmethylsulfonyl fluoride (PMSF), sodium
fluoride (NaF), sodium orthovanadate (Na3VO4), aproti-
nin, pepstatin, leupeptin, and human recombinant FGF9
were obtained from Sigma (St. Louis, MO, USA). Anti-
bodies against phospho-ERK-1/-2, ERK-1/-2, and GAPDH
as well as horseradish peroxidase-conjugated goat anti-
mouse IgG were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA).
Plant extracts and phenolic composition
We assayed different combinations of polyphenols in
extracts prepared at a final concentration of 100 mg/mL
in water or dimethyl sulfoxide from Aspalathus linearis
(family Fabaceae; rooibos leaves), Vitis vinifera (family
Vitaceae; grape seeds), Citrus aurantium (family Rutaceae;
bitter orange), Lippia citriodora (family Verbenaceae; lemon
verbena leaves), Olea europaea (family Oleaceae; olive
leaves), and Hibiscus sabdariffa (family Malvaceae;
karkade´). The criteria for inclusion were as follows: pre-
vious use in our laboratory in cell or animal models,
commercialization (usually to prepare beverages), chemi-
cal characterization, and safety for human consumption.
All extracts are readily available (Monteloeder, Elche,
Spain) and information on the composition is provided
in Supplementary Tables 1 and 2. Chromatographic
methods, along with any additional extended data and
references unique to these sections, are available as sup-
plementary information in the online version. Of note,
we also tested extracts from Hypoxis rooperi (family
Hypoxidaceae; African potato) to ensure the lack of
effects from lignans (data not shown). Because of distinct
and significant effects obtained from H. sabdariffa, we
only present a full report of data obtained with this mixture
and a new preparation to concentrate its phenolic com-
pounds. This concentration was performed via a described
procedure that eliminates the residual presence of sugar,
fiber, and other material, significantly reducing the con-
centration of organic acids and decreasing the concentra-
tion of prodelphinidin B3 (31) (Supplementary Table 2).
This concentrated extract was employed in subsequent ex-
periments to provide a concentration of compounds similar
to that after the addition of normal extract (10 mg/mL in
the culture medium).
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Cell culture and assessment of cell size and morphology
RCJ3.1C5.18 cells obtained from a mesenchymal cell
line that differentiates into chondrocytes were used to
test whether polyphenols modulate the FGF system. Cells
were stably transfected with full-length human wild type
(RCJ-FGFR3-WT) cells or with the G380R mutant
FGFR3 (RCJ-FGFR3-G380R) cells included in a vector
that overexpresses the receptor in absence of tetracycline,
following procedures previously described (32, 33). Mutated
FGFR3 (G380R) results in the overexpression of FGFR3,
Fig. 1. Intracellular chloride accumulation is modulated by polyphenols. Measurements are indicated as percentages with
respect to values obtained in wild type cells and the effect of the addition of FGF9 (25 ng/mL; 100%) or the respective controls
without FGF9 (0%). Data are expressed as the mean9SD (n69 independent experiments in triplicate), indicating the relative
increase or decrease in chloride concentration. (a) Among the different combinations of polyphenols, only those provided by
Hibiscus sabdariffa decreased intracellular chloride accumulation. In contrast, all other combinations favored the accumulation
of chloride. We decided to exclude these extracts in further analyses, and p values were provided only for H. Sabdariffa. (b) We
concentrated this extract to individualize the effect of polyphenols, assessing any potential contribution of residual compounds
and organic acids, and the values were compared with those obtained from the initial H. sabdariffa extract. Asterisks denote
significant effects with respect to controls.
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and in this model FGF9 provokes a reduction in cell
growth and aberrant morphological changes in chondro-
cytes. The required materials were obtained from ProChon
Biotech (Woburn, MA, USA). Cells were incubated at
378C with 5% CO2 in the standard a-MEM culture
medium supplemented with 15% heat-inactivated fetal
bovine serum and antibiotics (600 mg/mL Geneticin, 100
U/mL penicillin/streptomycin, and 50 mg/mL hygromycin)
with or without 2 mg/mL tetracycline. Results were pro-
vided by six independent experiments, in triplicate, and
trypan blue was employed to detect viable, unstained
cells. Cell size and morphology were monitored micro-
scopically, as previously described (28).
Chloride efflux measurements
To explore the effects of FGF9 in morphologic changes,
we first measured the FGFR3-regulated chloride flux
to assess the role of voltage gated chloride channels in
chondrogenesis (34). This method was employed as a
screening procedure to assess the potential benefits pro-
vided by polyphenols. In brief, measurements were made
using N-[ethoxycarbonylmethyl]-6-methoxy-quinolinium
bromide (MQAE) as a fluorescent indicator (35). MQAE
has a high sensitivity to chloride, and changes in fluore-
scence inversely reflect changes in intracellular chloride
concentration. Thus, a decrease in intracellular fluores-
cence indicates the conservation of or an increase in the
intracellular chloride concentration. In the same way, an
increase in fluorescence indicates a decrease in the intra-
cellular chloride concentration. In both cases, a significant
movement of water is produced with a consequent
change in the voltage of the membrane (36). As previously
published (28), measurements were made employing the
appropriate controls, and the final concentration of FGF9
was set at 25 ng/mL according to doseresponse experi-
ments. Cells were grown to confluence in 96-well plates
and loaded overnight with 0.8 mM MQAE at 378C. Then,
the medium was removed, washed, and incubated with
chloride-containing buffer (to induce chloride channel
activation) for 10 min at 378C. The buffer was then re-
moved and replaced by 100 mL of chloride-free buffer
containing the desired concentration of FGF9.
Assessment of ERK-1/-2 phosphorylation
Signals evoked by ligand-receptor interactions control
fundamental cellular processes in chondrocytes. The experi-
ments were focused to assess the previously unexplored
effects of H. sabdariffa on the ERK-1 and -2 components
of the MAPK cascade. ERK-1/-2 activation would re-
present an induction of chondrocyte maturation and, con-
versely, inhibition of ERK-1/-2 would suggest a blockade
of maturation and cell death (37). Cells were lysed in a
buffer with the following composition: 50 mM TrisHCl
pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium deox-
ycholate, 0.1% SDS, 1 mM PMSF, 1 mM NaF, 2 mM
Na3VO4, 10 mg/mL aprotinin, 5 mg/mL pepstatin, and
10 mg/mL leupeptin. After centrifugation at 13,000 g for
20 min at 48C, protein concentration was determined by
the Bio-Rad protein assay (Bio-Rad laboratories, Hercules,
CA, USA). Proteins from each sample (45 mg) were
Fig. 2. Relative ERK-1/-2 phosphorylation. Experiments were performed in FGFR3 (G380R) mutant RCJ3.1C5.18
chondrocytes with or without FGF9 (25 ng/mL) and further incubated with Hibiscus sabdariffa or its polyphenolic extract.
Data were combined and expressed as the mean9SD (n6, in triplicate). Representative results were included for illustrative
purposes.
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subjected to 10% SDS-polyacrylamide gels and were
transferred to nitrocellulose membranes (Amersham Phar-
macia Biotech, Buckinghamshire, UK). Membranes were
then blocked and incubated overnight with the primary
antibody in TBS containing 5% skim milk and 0.1%
TWEEN-20. After washing, blots were incubated with
horseradish peroxidase-conjugated goat anti-mouse IgG
secondary antibody (1:2,000). Development was performed
utilizing the ECL system (Amersham Pharmacia Biotech).
Films were scanned and analyzed using a Kodak GL 200
Imaging System with Kodak Molecular Imaging Software
(Rochester, NY, USA). Data are the result of six indepen-
dent experiments, in triplicate, and the overall procedure
was assessed using GAPDH as control.
Measurement of extracellular matrix secretion
The extracellular matrix (ECM) provides mechanical sup-
port and a spatial context for signaling events by various
cell surface growth factor receptors (38). We studied the
effects of H. sabdariffa extract and concentrated poly-
phenols in cartilage matrix deposition in chondrocytes
with a method based on Alcian blue staining (39). In
brief, reagents and protocols were obtained from Lifeline
Cell Technology (Frederick, MD, USA) and PromoCell
(Heidelberg, Germany). Cells were seeded at a density
of 2105 cells/well in six-well dishes, and differentiation
was induced by adding 10 mM b-glycerophosphate and
50 mg/mL ascorbic acid to the medium. Cultures were fed
with supplemented media every 2 days; FGF9 (25 ng/mL)
was added to fresh growth medium, alone or in combina-
tion with bioactive compounds. Under these conditions, the
amount of cartilage matrix (proteoglycan synthesis) was
measured at 3, 7, and 10 days of culture (39). At these time
points, cells were washed with PBS and stained with Alcian
blue stain (1% in 3% acetic acid) for 30 min, washed again
three times for 2 min in 3% acetic acid, and rinsed with
distilled water. Solubility was achieved with 1% SDS, 1 h
at 908C, to measure the absorbance at 605 nm.
Statistical analysis
All data are presented as the mean9SD. To test general
differences among means, we employed ANOVA, followed
Fig. 3. Extracellular matrix (ECM) deposition. Data were combined and expressed as the mean9SD (n6, in triplicate), and
the values indicate the amount of enrichment in the ECM utilizing Alcian blue staining of cells. Measurements were sequentially
performed at days 3, 7, and 10 and included untreated cells (control) and activated cells in the presence of Hibiscus sabdariffa
extract or its derived polyphenolic extract with or without FGF9 (25 ng/mL).
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by the Tukey-Kramer post-hoc test. To test specific dif-
ferences between means, homogenous variances were
assumed by the F-test, and Student’s t-test (two-sided)
was employed. PB0.05 was considered to be statistically
significant. Graphics were prepared with GraphPad Prism
6 (La Jolla, CA, USA) in combination with the statistical
software SPSS version 19 (Chicago, IL, USA).
Results and discussion
The expression in chondrocytes of the FGFR3 (G380R)
mutation is currently considered to be the likely cause
of the human chondrodysplasia, termed achondroplasia
(40, 41). In these patients, there is an over-activation of
FGFR3 in the presence of FGF9, which results in toxic
effects in chondrocytes, preventing endochondral bone for-
mation. Because this represents a gain-of-function mutation
and FGFR3 is a transmembrane receptor tyrosine kinase
that initiates signal transduction to the nucleus, it is re-
asonable to predict that successful therapeutic strategies
would decrease or eliminate FGFR3 signals. Using mouse
chondrocytes containing the human mutant FGFR3,
it has been possible to test the effects of polyphenols
and how these and other plant dietary compounds affect
intracellular signaling networks in an achondroplastic
model (2). To follow this approach, we measured the effect
of commercially available extracts commonly used in edible
preparations on the modulation of chloride efflux by
FGFR3 (G380R) and FGF9. The arrangement of FGF9
and FGFR3 in this model induced an enlarged achon-
droplastic chondrocyte size and an increase in the intra-
cellular chloride, which is likely the result of an inhibition
of the chloride efflux (42). Intriguingly, most polyphenol
combinations further increased the intracellular chloride
concentration and potentiated the deleterious effects in
chondrocytes (Fig. 1a). Quantitative effects, however,
differed considerably, andwe noted significant changes in cell
size and a disproportionate 15-fold increase in intra-
cellular chloride concentration caused by C. aurantium. In
response to the reproducibility of these data, we excluded
these dietary extracts in this study, but this information
will drive studies to further investigate the role of rest-
ing membrane potential in the normal development of
chondrocytes. Conversely, compounds from H. sabdariffa
restrained the increase in the intracellular chloride con-
centration (Fig. 1b). Interpretation is difficult because
data could indicate combined actions on FGFR3 sig-
naling, binding of FGF9, or direct preservation of the
membrane potential. Furthermore, analysis of the com-
position of the complex mixture of compounds in the
initial extract revealed that a significant amount of organic
acids and other materials were present together with
polyphenols. We then eliminated these residual compo-
nents to obtain an extract in which polyphenols were
concentrated. Subsequent experiments, once corrected
for the total amount of compounds, indicated that the
effect of polyphenols in the regulation of chloride efflux,
although significant, was less intense than that observed
in the initial extract (Fig. 1b and Supplementary Tables 1
and 2). Contrary to what we expected, the results suggest a
major role for organic acids, particularly hydroxycitric
acid, but attribution of the effect to a single component is
highly unlikely. Moreover, when we utilized both mixtures
derived from H. sabdariffa, polyphenols appeared to be
the compounds causing the inhibition of ERK-1/-2 (p42
and p44) phosphorylation. ERKs are important in cellular
growth and development (17, 4348), and the effects
were detectable in cultures without FGF9, but statistical
significance was only achieved in the presence of the ligand
(Fig. 2). This effect is relevant because ERK-1/-2 phos-
phorylation was activated in FGFR3 (G380R) chondro-
cytes challenged with FGF9, confirming our previous
findings (28). The role of the original H. sabdariffa extract
may not be inferred from our data because it had no
significant effect on the level of phosphorylation with
or without FGF9, but it has been shown to target other
multiple components (4954). However, we limited the
exploration to the MAPK pathway because ERK-1/-2
inhibition under these conditions is probably restricted to
chondrocytes, in which this signaling system regulates cell
growth, proliferation, and ECM accumulation (5562).
The stimulation by FGF9 of mutated FGFR3 also
results in a dramatic decrease in ECM production in chon-
drocytes, an action that was reversed by H. sabdariffa.
The effect was ostensible even in the absence of FGF9 and
reached statistical significance after 10 days of treatment
(Fig. 3). Total values were lower than those observed
in wild type cells, indicating the probable contribution
Fig. 4. Chondrocyte proliferation comparing untreated cells
(control) and treated cells with Hibiscus sabdariffa and its
polyphenolic extract with or without FGF9 (25 ng/mL). Cell
viability was determined by the trypan blue method. Data
are expressed as mean9SD (n6, in triplicate).
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of other mechanisms, but active studies suggest that the
differences are reduced with longer exposure time and
higher concentrations (data not shown). ECM enrichment
improves chondrocyte physiology due to the optimization
of the signaling microenvironment of FGFs (63, 64). This
effect is relevant in this environment because the forma-
tion of molecular complexes between growth factors and
ECM proteins regulates dynamic interactions between
proteins, bioavailability and function of many growth
factors, and the modulation of FGFR signaling (6567).
It is therefore plausible that, in skeletal dysplasia and
in diseases with prominently degraded cartilage, FGF9/
FGFR3 modulators could prevent cartilage degeneration
and/or promote cartilage regeneration (68, 69).
Fig. 5. Illustrative summary of observed and proposed effects in the mutant chondrocyte model. Polyphenols target multiple
components that promote and maintain tissue homeostasis beyond their anti-inflammatory and antioxidant effects, and their
actions might be extended to disease prevention and intervention. Binding of fibroblast growth factor (FGF9) to its receptor
(FGFR3) activates several important signaling pathways that are associated with the overall response to inflammation and are
crucial in chondrocytes to regulate cell proliferation and extracellular matrix (ECM) generation. From the data, we consider the
possibility that the action of complete Hibiscus sabdariffa extract might be different from that observed with concentrated
polyphenols. In particular, polyphenols appear more active in the inhibition of ERK-1/-2 phosphorylation and in the increase
of ECM generation, whereas the combination of organic acids and polyphenols could be more active in reversing the intracellular
chloride accumulation and increasing cellular proliferation. H. sabdariffa reverses the toxic actions of the FGF9/FGFR3 inter-
action in mutated chondrocytes. The results indicate the need for a search for human models to fully establish actual mechanisms
as well as the potential modification of diets to achieve human health benefits. AKT (PKB): protein kinase B; ERK 1/2 (MAPK):
extracellular signal-regulated kinases 1 and 2; FGF: fibroblast growth factor; FGFR: fibroblast growth factor receptor; MEK1/2:
MAPK kinases 1 and 2; PI-3K: phosphatidylinositide 3-kinase; PLCg: phospholipase C gamma; RAF: rapidly accelerated
fibrosarcoma (serine/threonine-protein kinase); RAS: rat sarcoma protein (GTPase); STAT1: signal transducer and activator of
transcription 1.
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Accordingly, chondrocyte viability is low when cells
bear the (G380R) mutation of FGFR3, the likely con-
sequence of increased maturation and early cell death
(70, 71). The effect is highly dependent on the presence
of the ligand (FGF9), indicating the importance of active
growth factors in the vicinity. In this model, FGF9
decreased cell survival in a few hours. H. sabdariffa treat-
ment completely reversed the action of FGF9, and cell pro-
liferation was similar to that observed in controls (Fig. 4),
indicating the rescue of the FGFR3 (G380R) phenotype.
Experiments should follow to ascertain whether individual
compounds may elicit similar beneficial effects. How-
ever, safe concentrations are more difficult to achieve, and
observations in animal models suggest that the synergistic
action of natural compounds is a more likely possibility
(3, 31, 55). Stronger evidence could be provided by the
development of better in vivo and in vitro models employ-
ing human cells. It should be mentioned that recent cell
reprogramming technologies might be utilized to obtain
induced pluripotent stem cells differentiated into mutant
chondrocytes that may confirm the anabolic effects we
have found in chondrocytes treated with bioactive com-
pounds from H. sabdariffa. As preliminary results, im-
munoprecipitation experiments of FGFR3 suggest that
these bioactive compounds are not affecting the receptor
directly. Thus, the exploration of related signaling path-
ways other than ERK-1/-2 in chondrocytes and the effect
of some available drugs might also contribute to fully
uncovering the actual molecular mechanisms (7274).
Perhaps it is time to contemplate significant dietary modi-
fications in humans by food design and supplementation
to obtain health benefits (75).
Conclusion
With the rationale that some nutrients with intrinsic anti-
inflammatory and antioxidative effects may mitigate a
deleterious response leading to degraded cartilage, we
assayed the activity of dietary polyphenols in murine cells
with the transduced human (G380R) mutation in FGFR3.
Most polyphenols had no effect, but those provided by
H. sabdariffa rescued chondrocytes from FGF9-induced
toxic effects, supporting the view that plant-derived diet-
ary products affect intracellular signaling networks and
may be safely utilized in the management of degraded car-
tilage phenotypes. H. sabdariffa rescued mutated FGFR3
chondrocytes, restoring normal growth, decreasing the
intracellular chloride concentration, inhibiting ERK-1/-2
phosphorylation, and increasing the generation of ECM
(Fig. 5). Our data indicate the crucial role of growth fac-
tors in the survival of chondrocytes and suggest effective
and applicable therapeutic strategies for patients with
degraded cartilage. H. sabdariffa would have the advan-
tage that it has been safely administered to large numbers
of humans for millennia, including pregnant women and
infants.
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